Global Drug Discovery Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Drug Discovery Services Market is presumed to reach the market size of nearly USD 86.34 Billion by 2032 from USD 25.15 Billion in 2023 with a CAGR of 14.69% under the study period 2024-2032.

Drug discovery services involve various specialized activities to identify and develop new pharmaceutical compounds. These services include target identification, hit-to-lead optimization, preclinical testing, and early-phase clinical trials. These services are provided by contract research organizations (CROs), which offer expertise in various aspects of drug development, including molecular modeling, high-throughput screening, and bioinformatics. These services aim to accelerate the discovery process, reduce costs, and improve the likelihood of successful drug development. By providing comprehensive support from initial research through early clinical stages, these services play a crucial role in bringing new therapies to market. The increasing demand for innovative drugs and the growing complexity of drug development processes drive the market for these services.

MARKET DYNAMICS

The drug discovery services market is driven by the increasing complexity of drug development, which necessitates specialized services to manage various stages of the discovery process. As pharmaceutical companies face growing challenges in developing new therapies, they increasingly rely on drug discovery services to provide expertise, advanced technologies, and streamlined processes that enhance efficiency and effectiveness. Technological advancements offer significant opportunities within the market. Innovations such as artificial intelligence & machine learning are transforming drug discovery by enabling faster and more accurate identification of potential drug candidates. These technologies facilitate predictive modeling, data analysis, and virtual screening, significantly accelerating the discovery process and improving success rates.

The propelling prevalence of chronic diseases and the need for new treatments drive market growth. As the global burden of conditions such as cancer, cardiovascular diseases, and neurodegenerative disorders increases, there is a growing demand for innovative therapies. Drug discovery services play a crucial role in addressing this need by supporting the development of novel treatments and therapies. Additionally, the trend towards outsourcing drug discovery activities to specialized CROs creates further opportunities. Pharmaceutical companies seek to reduce costs and improve focus by partnering with CROs that offer specialized expertise and advanced technologies. However, the high cost of these services and the lengthy development timelines can hamper market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Drug Discovery Services. The growth and trends of Drug Discovery Services industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Drug Discovery Services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Process

Target Selection
Target Validation
Hit-to-Lead Identification
Lead Optimization
Candidate Validation

By Type

Chemistry Services
Biological Services

By Drug Type

Small-Molecule Drugs
Large-Molecule Drugs

By Therapeutic Area

Diabetes
Neurology
Oncology
Infectious Diseases
Other Therapeutic Areas

By End-user

Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Other End-users

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Drug Discovery Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Drug Discovery Services market include Charles River Laboratories International Inc., Thermo Fisher Scientific Inc., Wuxi AppTec, Eurofins Scientific, . This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112115522

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. DRUG DISCOVERY SERVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Process
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By Drug Type
- 3.7.4 Market Attractiveness Analysis By Therapeutic Area
- 3.7.5 Market Attractiveness Analysis By End-user
- 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL DRUG DISCOVERY SERVICES MARKET ANALYSIS BY PROCESS

5.1. Overview By Process
5.2. Historical and Forecast Data Analysis By Process
5.3. Target Selection Historic and Forecast Sales By Regions
5.4. Target Validation Historic and Forecast Sales By Regions
5.5. Hit-to-Lead Identification Historic and Forecast Sales By Regions
5.6. Lead Optimization Historic and Forecast Sales By Regions
5.7. Candidate Validation Historic and Forecast Sales By Regions

6. GLOBAL DRUG DISCOVERY SERVICES MARKET ANALYSIS BY TYPE

6.1. Overview By Type
6.2. Historical and Forecast Data Analysis By Type
6.3. Chemistry Services Historic and Forecast Sales By Regions
6.4. Biological Services Historic and Forecast Sales By Regions

7. GLOBAL DRUG DISCOVERY SERVICES MARKET ANALYSIS BY DRUG TYPE

7.1. Overview By Drug Type
7.2. Historical and Forecast Data Analysis By Drug Type
7.3. Small-Molecule Drugs Historic and Forecast Sales By Regions
7.4. Large-Molecule Drugs Historic and Forecast Sales By Regions

8. GLOBAL DRUG DISCOVERY SERVICES MARKET ANALYSIS BY THERAPEUTIC AREA

8.1. Overview By Therapeutic Area
8.2. Historical and Forecast Data Analysis By Therapeutic Area
8.3. Diabetes Historic and Forecast Sales By Regions
8.4. Neurology Historic and Forecast Sales By Regions
8.5. Oncology Historic and Forecast Sales By Regions
8.6. Infectious Diseases Historic and Forecast Sales By Regions
8.7. Other Therapeutic Areas Historic and Forecast Sales By Regions

9. GLOBAL DRUG DISCOVERY SERVICES MARKET ANALYSIS BY END-USER

9.1. Overview By End-user
9.2. Historical and Forecast Data Analysis By End-user
9.3. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
9.4. Contract Research Organizations Historic and Forecast Sales By Regions
9.5. Other End-users Historic and Forecast Sales By Regions

10. GLOBAL DRUG DISCOVERY SERVICES MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1 Overview, Historic and Forecast Data Sales Analysis
- 10.3.2 North America By Segment Sales Analysis
- 10.3.3 North America By Country Sales Analysis
- 10.3.4 United States Sales Analysis
- 10.3.5 Canada Sales Analysis
- 10.3.6 Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1 Overview, Historic and Forecast Data Sales Analysis
- 10.4.2 Europe By Segment Sales Analysis
- 10.4.3 Europe By Country Sales Analysis
- 10.4.4 United Kingdom Sales Analysis
- 10.4.5 France Sales Analysis
- 10.4.6 Germany Sales Analysis
- 10.4.7 Italy Sales Analysis
- 10.4.8 Russia Sales Analysis
- 10.4.9 Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1 Overview, Historic and Forecast Data Sales Analysis
- 10.5.2 Asia Pacific By Segment Sales Analysis
- 10.5.3 Asia Pacific By Country Sales Analysis
- 10.5.4 China Sales Analysis
- 10.5.5 India Sales Analysis
- 10.5.6 Japan Sales Analysis
- 10.5.7 South Korea Sales Analysis
- 10.5.8 Australia Sales Analysis
- 10.5.9 South East Asia Sales Analysis
- 10.5.10 Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1 Overview, Historic and Forecast Data Sales Analysis
- 10.6.2 Latin America By Segment Sales Analysis
- 10.6.3 Latin America By Country Sales Analysis
- 10.6.4 Brazil Sales Analysis
- 10.6.5 Argentina Sales Analysis
- 10.6.6 Peru Sales Analysis
- 10.6.7 Chile Sales Analysis
- 10.6.8 Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1 Overview, Historic and Forecast Data Sales Analysis
- 10.7.2 Middle East & Africa By Segment Sales Analysis
- 10.7.3 Middle East & Africa By Country Sales Analysis
- 10.7.4 Saudi Arabia Sales Analysis
- 10.7.5 UAE Sales Analysis
- 10.7.6 Israel Sales Analysis
- 10.7.7 South Africa Sales Analysis
- 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE DRUG DISCOVERY SERVICES COMPANIES

11.1. Drug Discovery Services Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12. COMPANY PROFILES OF DRUG DISCOVERY SERVICES INDUSTRY

12.1. Top Companies Market Share Analysis
12.2. Market Concentration Rate
12.3. Charles River Laboratories International Inc.
- 12.3.1 Company Overview
- 12.3.2 Company Revenue
- 12.3.3 Products
- 12.3.4 Recent Developments
12.4. Thermo Fisher Scientific Inc.
- 12.4.1 Company Overview
- 12.4.2 Company Revenue
- 12.4.3 Products
- 12.4.4 Recent Developments
12.5. Wuxi AppTec
- 12.5.1 Company Overview
- 12.5.2 Company Revenue
- 12.5.3 Products
- 12.5.4 Recent Developments
12.6. Eurofins Scientific
- 12.6.1 Company Overview
- 12.6.2 Company Revenue
- 12.6.3 Products
- 12.6.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies